Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review
Description
Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation, is a pharmaceutical company that develops and distributes complementary products, over-the-counter drugs, prescription drugs, natural and consumer health care products, and dermo-cosmetics. The company provides treatment for oncology, dermatology, rare diseases, chronic diseases, smoking cessation, consumer healthcare, natural health, and oral health. Pierre Fabre offers its products to customers through healthcare professionals and a network of pharmacies and drugstores under the brands Eau Thermale Avene, Ducray, Klorane, A-Derma, Rene Furterer, Darrow, Dexeryl, among others. It operates in various countries globally, including China, Germany, Spain, Italy, the US, Mexico, Brazil, and Poland, among others. Pierre Fabre is headquartered in Paris, Ile-de-France, France.
Laboratoires Pierre Fabre SA Key Recent Developments
Jan 29,2026: Emmanuelle Hocquard de Kerleau Appointed Chief Impact and Reputation Officer
Jan 12,2026: Pierre Fabre Pharmaceuticals Statement on FDA Complete Response Letter for Tabelecleucel Biologics License Application
Jan 09,2026: Pierre Fabre Laboratories and Iktos Collaborate on AI-Based Oncology Drug Discovery
Dec 17,2025: Oncology: Pierre Fabre unveils an innovative plan to improve patients' quality of life
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation, is a pharmaceutical company that develops and distributes complementary products, over-the-counter drugs, prescription drugs, natural and consumer health care products, and dermo-cosmetics. The company provides treatment for oncology, dermatology, rare diseases, chronic diseases, smoking cessation, consumer healthcare, natural health, and oral health. Pierre Fabre offers its products to customers through healthcare professionals and a network of pharmacies and drugstores under the brands Eau Thermale Avene, Ducray, Klorane, A-Derma, Rene Furterer, Darrow, Dexeryl, among others. It operates in various countries globally, including China, Germany, Spain, Italy, the US, Mexico, Brazil, and Poland, among others. Pierre Fabre is headquartered in Paris, Ile-de-France, France.
Laboratoires Pierre Fabre SA Key Recent Developments
Jan 29,2026: Emmanuelle Hocquard de Kerleau Appointed Chief Impact and Reputation Officer
Jan 12,2026: Pierre Fabre Pharmaceuticals Statement on FDA Complete Response Letter for Tabelecleucel Biologics License Application
Jan 09,2026: Pierre Fabre Laboratories and Iktos Collaborate on AI-Based Oncology Drug Discovery
Dec 17,2025: Oncology: Pierre Fabre unveils an innovative plan to improve patients' quality of life
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
42 Pages
- Section 1 - About the Company
- Laboratoires Pierre Fabre SA - Key Facts
- Laboratoires Pierre Fabre SA - Key Employees
- Laboratoires Pierre Fabre SA - Key Employee Biographies
- Laboratoires Pierre Fabre SA - Major Products and Services
- Laboratoires Pierre Fabre SA - History
- Laboratoires Pierre Fabre SA - Company Statement
- Laboratoires Pierre Fabre SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Affiliate
- Section 2 – Company Analysis
- Company Overview
- Laboratoires Pierre Fabre SA - Business Description
- Business Segment: Dermo Cosmetics and Personal Care
- Overview
- Business Segment: Medical Care
- Overview
- Performance
- Geographical Segment: Africa, Middle , Turkey
- Performance
- Geographical Segment: Americas
- Performance
- Geographical Segment: Asia, Paicifc
- Performance
- Geographical Segment: Europe
- Performance
- Geographical Segment: France
- Performance
- R&D Overview
- Laboratoires Pierre Fabre SA - Corporate Strategy
- Laboratoires Pierre Fabre SA - SWOT Analysis
- SWOT Analysis - Overview
- Laboratoires Pierre Fabre SA - Strengths
- Laboratoires Pierre Fabre SA - Weaknesses
- Laboratoires Pierre Fabre SA - Opportunities
- Laboratoires Pierre Fabre SA - Threats
- Laboratoires Pierre Fabre SA - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Laboratoires Pierre Fabre SA, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Jan 29, 2026: Emmanuelle Hocquard de Kerleau Appointed Chief Impact and Reputation Officer
- Jan 12, 2026: Pierre Fabre Pharmaceuticals Statement on FDA Complete Response Letter for Tabelecleucel Biologics License Application
- Jan 09, 2026: Pierre Fabre Laboratories and Iktos Collaborate on AI-Based Oncology Drug Discovery
- Dec 17, 2025: Oncology: Pierre Fabre unveils an innovative plan to improve patients' quality of life
- Oct 03, 2025: Campus Chartreuse Inaugurated As New Headquarters For Pierre Fabre Laboratories
- Jun 18, 2025: Pierre Fabre Laboratories Announces Inauguration of New US Office in Secaucus, New Jersey
- May 20, 2025: Pierre Fabre USA Unites with Breast Cancer Alliance to Advance Breast Cancer Surgery
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Laboratoires Pierre Fabre SA, Key Facts
- Laboratoires Pierre Fabre SA, Key Employees
- Laboratoires Pierre Fabre SA, Key Employee Biographies
- Laboratoires Pierre Fabre SA, Major Products and Services
- Laboratoires Pierre Fabre SA, History
- Laboratoires Pierre Fabre SA, Subsidiaries
- Laboratoires Pierre Fabre SA, Affiliate
- Laboratoires Pierre Fabre SA, Key Competitors
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Laboratoires Pierre Fabre SA, Recent Deals Summary
- List of Figures
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

